2nd Study Links Heartburn Drugs To Kidney Damage

(April 15, 2016, 12:03 PM EDT) -- WASHINGTON, D.C. — Exposure to proton pump inhibitor (PPI) heartburn drugs is associated with an increased risk of incident chronic kidney disease (CKD), CKD progression and end-stage renal disease (ESRD), according to an April 14 early release five-year cohort study to be published in the Journal of the American Society of Nephrology (“Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESDR,” Yan Xie, et al., Jour. American Soc. Of Nephrology, April 14, 2016).

The authors say association between PPIs and acute interstitial nephritis...
To view the full article, register now.